PHORMED ANNOUNCES ARDS STUDY RESULTS ...Middle East

News by : (PR Newswire) -
CENTURY CITY, Calif., Aug. 3, 2022 /PRNewswire/ -- PhorMed Inc, a Nevada Corporation ("PhorMed" or the "Company"), is a privately held clinical stage biopharmaceutical company. The Company's study drug RP-323 is in an on-going acute respiratory distress syndrome (ARDS) study. ARDS is a...

Read More Details
Finally We wish PressBee provided you with enough information of ( PHORMED ANNOUNCES ARDS STUDY RESULTS )

Also on site :

Most Viewed News
جديد الاخبار